Literature DB >> 29115296

Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up.

F Pizzolo1, G Salvagno2, B Caruso3, C Cocco3, F Zorzi1, C Zaltron1, A Castagna1, L Bertolone1, F Morandini1, G Lippi2, O Olivieri1.   

Abstract

Aldosterone and renin measurement is a cornerstone for primary aldosteronism (PA) diagnosis, but different thresholds are used according to different assays. A fully automated chemiluminescence (CL) immunoassay for renin and aldosterone was recently proposed, showing good performance for PA screening by aldosterone to renin ratio (ARR). This study aimed to define the accuracy of this assay in the screening and in the most popular confirmatory test of autonomous aldosterone production, the intravenous saline loading test (ivSLT). We compared aldosterone results obtained by CL vs radioimmunoassay (RIA) in hypertensive patients investigated for PA (102 baseline and 85 after ivSLT). An excellent correlation was observed between RIA and CL in the entire population for aldosterone (r=0.922) and ARR (r=0.977). For ARR, Deming regression proved a good accordance between methods and, consistent with the fit model, our previous institutional ARR cut-off of 32 (pg ml-1)/(pg ml-1) corresponded to 20 pg ml-1 mU-1 l-1 in CL assay. However, the correlation was weaker in the low end of aldosterone concentrations (r=0.676 for aldosterone <100 pg ml-1), with a concordance of ivSLT results in only 68% of patients. CL assay displays a diagnostic performance very similar to RIA for ARR screening, but it is substantially inferior in the setting of confirmatory tests of autonomous aldosterone secretion, that is, ivSLT.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29115296     DOI: 10.1038/jhh.2017.62

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  27 in total

1.  Primary aldosteronism: are we missing the wood for the trees?

Authors:  J W Funder
Journal:  Horm Metab Res       Date:  2012-01-26       Impact factor: 2.936

2.  Plasma aldosterone assays: comparison between chemiluminescence-based and RIA methods.

Authors:  Francesca Pizzolo; Angela Corgnati; Patrizia Guarini; Chiara Pavan; Antonella Bassi; Roberto Corrocher; Oliviero Olivieri
Journal:  Clin Chem       Date:  2006-07       Impact factor: 8.327

3.  Captopril test can give misleading results in patients with suspect primary aldosteronism.

Authors:  Paolo Mulatero; Chiara Bertello; Corrado Garrone; Denis Rossato; Giulio Mengozzi; Andrea Verhovez; Francesco Fallo; Franco Veglio
Journal:  Hypertension       Date:  2007-06-18       Impact factor: 10.190

4.  Enhancement of specificity of aldosterone measurement in human serum and plasma using 2D-LC-MS/MS and comparison with commercial immunoassays.

Authors:  Julie A Ray; Mark M Kushnir; John Palmer; Seyed Sadjadi; Alan L Rockwood; A Wayne Meikle
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-09-06       Impact factor: 3.205

5.  Confirmatory testing in primary aldosteronism.

Authors:  Kazutaka Nanba; Tamiko Tamanaha; Kanako Nakao; Sachiko-Tsukamoto Kawashima; Takeshi Usui; Tetsuya Tagami; Hiroshi Okuno; Akira Shimatsu; Tomoko Suzuki; Mitsuhide Naruse
Journal:  J Clin Endocrinol Metab       Date:  2012-03-14       Impact factor: 5.958

6.  Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism.

Authors:  Gian Paolo Rossi; Vitantonio Di Bello; Chiara Ganzaroli; Alfredo Sacchetto; Maurizio Cesari; Alessio Bertini; Davide Giorgi; Roldano Scognamiglio; Mario Mariani; Achille C Pessina
Journal:  Hypertension       Date:  2002-07       Impact factor: 10.190

7.  Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry.

Authors:  Paul J Taylor; Donald P Cooper; Richard D Gordon; Michael Stowasser
Journal:  Clin Chem       Date:  2009-04-09       Impact factor: 8.327

8.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

9.  NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism.

Authors:  Francesca Pizzolo; Francesco Zorzi; Laura Chiecchi; Letizia Consoli; Irene Aprili; Patrizia Guarini; Annalisa Castagna; Gian Luca Salvagno; Chiara Pavan; Oliviero Olivieri
Journal:  Endocrine       Date:  2013-08-13       Impact factor: 3.633

10.  Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension.

Authors:  Gian Paolo Rossi; Giulio Ceolotto; Giacomo Rossitto; Teresa Maria Seccia; Giuseppe Maiolino; Chiara Berton; Daniela Basso; Mario Plebani
Journal:  Clin Chem Lab Med       Date:  2016-09-01       Impact factor: 3.694

View more
  4 in total

1.  Feasibility of Screening Primary Aldosteronism by Aldosterone-to-Direct Renin Concentration Ratio Derived from Chemiluminescent Immunoassay Measurement: Diagnostic Accuracy and Cutoff Value.

Authors:  Tianqi Li; Yeshuo Ma; Ying Zhang; Yue Liu; Tingting Fu; Ri Zhang; Kai Kang; Yingchao Yang; Lixin Wang; Yinong Jiang; Yan Lu
Journal:  Int J Hypertens       Date:  2019-07-02       Impact factor: 2.420

2.  Detection of Urinary Exosomal HSD11B2 mRNA Expression: A Useful Novel Tool for the Diagnostic Approach of Dysfunctional 11β-HSD2-Related Hypertension.

Authors:  Domenica De Santis; Annalisa Castagna; Elisa Danese; Silvia Udali; Nicola Martinelli; Francesca Morandini; Mariangela Veneri; Lorenzo Bertolone; Oliviero Olivieri; Simonetta Friso; Francesca Pizzolo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-23       Impact factor: 5.555

3.  Re-Assessment of the Oral Salt Loading Test Using a New Chemiluminescent Enzyme Immunoassay Based on a Two-Step Sandwich Method to Measure 24-Hour Urine Aldosterone Excretion.

Authors:  Yoshinori Ozeki; Mizuki Kinoshita; Shotaro Miyamoto; Yuichi Yoshida; Mitsuhiro Okamoto; Koro Gotoh; Takayuki Masaki; Kengo Kambara; Hirotaka Shibata
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-21       Impact factor: 5.555

4.  Development of a New Chemiluminescent Enzyme Immunoassay Using a Two-Step Sandwich Method for Measuring Aldosterone Concentrations.

Authors:  Yoshinori Ozeki; Yukie Tanimura; Satoshi Nagai; Takuya Nomura; Mizuki Kinoshita; Kanako Shibuta; Naoki Matsuda; Shotaro Miyamoto; Yuichi Yoshida; Mitsuhiro Okamoto; Koro Gotoh; Takayuki Masaki; Kengo Kambara; Hirotaka Shibata
Journal:  Diagnostics (Basel)       Date:  2021-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.